India MCA Insolvency Liquidation Filings — May 13, 2026

India MCA Insolvency & Restructuring Monitor

By Gunpowder Editorial ·

6 high priority 6 total filings analysed

Executive Summary

The India MCA Insolvency & Restructuring Monitor reveals mixed outcomes across 6 filings spanning dairy, chemicals, textiles, real estate, and biotech sectors, with 2 positive developments (Heranba dismissal, Kobo resolution approval) offsetting 3 high-materiality distress signals (Tasty Dairy's ongoing CIRP with qualified audits and net loss, Parsvnath's new CIRP commencement).

No explicit YoY/QoQ revenue or margin trends reported due to CIRP suspensions limiting operational disclosures, but Kobo's pre-CIRP net worth of ₹132.91 Cr vs assets ₹71.39 Cr highlights solvency gaps closed via ₹70.11 Cr creditor payouts. Critical advancements include Morarjee Textiles' post-resolution IMC constitution and Kobo's merger-demerger averting liquidation, signaling potential turnarounds, while Tasty and Parsvnath underscore deepening distress with uncertain recoverability and 180-day CIRP timelines. Portfolio-level pattern: 3/6 filings (50%) involve resolution progress (neutral/mixed/positive sentiment), vs 50% negative with qualified opinions/material impacts. Market implications favor selective longs in resolved cases amid broader IBC fatigue, with NCLT orders clustering in May 2026 creating short-term volatility.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Insolvency

Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from May 12, 2026.

Investment Signals (10)

  • NCLT dismissed Section 9 IBC application against wholly-owned subsidiary Heranba Organics Pvt Ltd on May 12, 2026, as principal debt below threshold post-interest exclusion; company confirms no material adverse impact

  • NCLT-approved resolution plan led to IMC constitution on May 11, 2026 (Mr. Ravi Sethia, resolution applicant rep, bank rep); CIRP ongoing since Feb 2024 signals structured exit nearing

  • NCLT Hyderabad approved Beaufond Industries' resolution plan on May 11, 2026 with ₹70.11 Cr payouts (₹67.78 Cr financial creditors, ₹2.30 Cr CIRP costs), merger-demerger averting liquidation despite pre-CIRP net worth ₹132.91 Cr > assets ₹71.39 Cr

  • Audited FY26 results under CIRP (since Oct 7, 2025) show net loss with qualified auditor opinion on litigation, SARFAESI sales, impairment, Ind AS non-compliance, and recoverability uncertainties; potential material pervasive impacts

  • NCLT New Delhi ordered CIRP commencement Apr 30, 2026 (order May 12), IRP Manoj Kumar Anand appointed, claims deadline May 27, 2026; 180-day process to Oct 27, 2026 amid no positive metrics

  • Prior intimation Feb 27, 2026 on same application now resolved positively, no CIRP initiation reinforces subsidiary stability and parent insulation

  • Kobo Biotech (NEUTRAL-BULLISH)

    Public shareholders diluted from 55.05% to 2% post-scheme but liabilities extinguished, resolution applicant net worth ₹333.18 Cr (Mar 2025) supports execution; monitoring committee oversees till handover

  • CIRP case CP(IB) No. 1318/MB-VI/2022 progresses to IMC phase post-plan approval, vs earlier interim RP Feb 9, 2024; relative outperformance vs ongoing CIRPs like Tasty

  • Duplicate FY26 results filing confirms persistent CIRP moratorium (Section 14 IBC), board powers suspended, RP Anish Agarwal approval May 12, 2026; heightened uncertainty vs resolved peers

  • 36-year-old realty firm (inc. 1990) enters CIRP with no forward ops guidance, contrasting Kobo/Morarjee resolutions; potential asset liquidation risk

Risk Flags (7)

  • Auditor Neha B Agarwal & Co flags unresolved litigations, unrecognized SARFAESI PPE sales, no impairment testing, Ind AS gaps, uncertain receivables/payables; material pervasive impacts unascertainable

  • CIRP effective Apr 30, 2026 with claims by May 27; 180-day timeline to Oct 27 risks liquidation if no viable plan, no financial/ops metrics disclosed

  • Tasty Dairy/Ongoing CIRP [MEDIUM-HIGH RISK]

    CIRP since Oct 7, 2025 (RP Anish Agarwal, IBBI reg. 12256) with net loss FY26; board suspended, moratorium limits adjustments vs peers like Heranba dismissal

  • Public stake drops 55.05% to 2.00%, no shares to pre-scheme promoters; incomplete new board details post-approval May 11, 2026

  • Ongoing since interim RP Feb 9, 2024; IMC constitution May 11, 2026 delays full handover, execution risks persist

  • Strict May 27, 2026 deadline for claims submission to IRP; potential disputes echo Tasty's litigation issues

  • Results approved May 12, 2026 (14:00-14:30) under RP oversight; qualified opinion worse than standard audits in resolved cases like Kobo

Opportunities (7)

  • NCLT rejection of CIRP vs subsidiary (May 12, 2026) removes overhang; scrip 543266/HERANBA undervalued post-Feb 27 intimation, potential re-rating

  • IMC setup post-NCLT May 11 order enables monitoring till implementation; trade near distress levels despite plan approval, turnaround alpha

  • ₹70.11 Cr creditor settlement (67% financial) via merger-demerger; Beaufond's ₹333 Cr net worth backs execution, acquisition play post-May 11

  • Fresh CIRP (Apr 30 start) with 180-day window; monitor claims May 27 for resolution applicants, potential asset carve-outs undervalued

  • HOPL to pursue legal steps post-dismissal; parent Heranba unscathed, relative strength vs new CIRPs like Parsvnath

  • All pre-CIRP claims wiped post-scheme; monitoring committee bridge to new board offers stability premium vs ongoing Tasty CIRP

  • Secured bank rep in IMC ensures creditor alignment; contrasts Tasty's uncertainties, position for post-CIRP equity upside

Sector Themes (5)

  • Resolution Approvals Accelerating

    2/6 filings (Morarjee Textiles, Kobo Biotech) show NCLT approvals/IMC (May 11, 2026), vs 1 dismissal (Heranba); implies 50% success rate shortening CIRPs, bullish for textiles/biotech recovery

  • Realty/Dairy Distress Persisting

    Parsvnath new CIRP (Apr 30, 2026) and Tasty ongoing (since Oct 2025) with qualified audits/net loss; 2/6 filings (33%) highlight recoverability risks, sector laggards vs resolved peers

  • Creditor Payout Structures Varying

    Kobo's ₹70.11 Cr total (97% financial creditors) vs no payouts in ongoing CIRPs; aggregate trend favors financial creditors in approvals, watch dilutions (Kobo public -53%)

  • NCLT Timelines Tightening

    May 11-12 cluster of orders (4/6 filings); 180-day CIRP cap (Parsvnath to Oct 27) pressures quick resolutions, creating Q3 2026 catalyst density

  • Qualified Opinions Prevalent in Ongoing CIRPs

    Tasty's dual filings flag litigation/SARFAESI/impairment issues (material unascertainable); contrasts clean approvals in Kobo/Morarjee, signals higher execution risk

Watch List (7)

Filing Analyses (6)
Tasty Dairy Specialities Limited Insolvency negative materiality 10/10

13-05-2026

Tasty Dairy Specialities Limited, under Corporate Insolvency Resolution Process (CIRP) since October 07, 2025 managed by Resolution Professional Anish Agarwal, submitted audited standalone financial results for the quarter and year ended March 31, 2026, approved by the RP on May 12, 2026. The auditor issued a qualified opinion due to multiple issues including incomplete litigation records, unrecognized SARFAESI asset sales, lack of impairment testing, Ind AS non-compliance from CIRP limitations, and uncertain trade receivables/payables recoverability, with potential material impacts unascertainable. The results reflect a net loss for the period amid suspended board powers and ongoing CIRP.

  • · CIRP order dated October 07, 2025; IP Registration No.: IBBI/IPA-001/IP-P-01497/2018-2019/12256
  • · Scrip Code: 540955, ISIN: INE773Y01014
  • · Financial results approved between 14:00 Hours and 14:30 Hours on May 12, 2026
  • · Auditor notes moratorium under Section 14 of Insolvency and Bankruptcy Code, 2016 in effect
Heranba Industries Limited Insolvency positive materiality 7/10

13-05-2026

The Hon’ble National Company Law Tribunal (NCLT), Mumbai Bench-VI, dismissed the application filed by Haresh Petrochem Private Limited under Section 9 of the Insolvency and Bankruptcy Code, 2016 against Heranba Organics Private Limited (wholly-owned subsidiary of Heranba Industries Limited) via Order No. CP (IB)/190(MB)2026 dated May 12, 2026. The dismissal was due to the principal operational debt falling below the threshold under Section 4 of the IBC after excluding the interest component claimed by the applicant, resulting in no Corporate Insolvency Resolution Process (CIRP) being initiated. The company confirms no material adverse impact on Heranba Industries Limited.

  • · Scrip Code: 543266, Symbol: HERANBA
  • · Previous intimation dated February 27, 2026
  • · HOPL may take necessary steps as advised under applicable law
Morarjee Textiles Limited Insolvency neutral materiality 9/10

13-05-2026

Morarjee Textiles Limited disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015, the constitution of the Implementation and Monitoring Committee (IMC) as per NCLT Mumbai order dated May 11, 2026, following Resolution Plan approval. The IMC includes Mr. Ravi Sethia (erstwhile Resolution Professional), a representative of Advocate Jatin Kumar for Shriniwas Spintex Industries Private Limited (Resolution Applicant), and a representative of Secured Indian Bank Financial Creditors. The company continues under Corporate Insolvency Resolution Process (CIRP) of IBC 2016, managed by Mr. Ravi Sethia since his interim appointment on February 9, 2024.

  • · Previous disclosure dated May 12, 2026
  • · NCLT case: CP(IB) No. 1318/MB-VI/2022
  • · Interim RP appointment: February 9, 2024
  • · RP confirmation by Committee of Creditors: May 22, 2024
  • · Company CIN: L52322MH1995PLC090643
  • · Stock codes: BSE 532621, NSE MORARJEE
Parsvnath Developers Limited Insolvency negative materiality 10/10

13-05-2026

The National Company Law Tribunal, Court II, New Delhi, has ordered the commencement of the Corporate Insolvency Resolution Process (CIRP) for Parsvnath Developers Limited effective 30 April 2026 (order received on 12 May 2026), signaling significant financial distress. Manoj Kumar Anand (IBBI/IPA-001/IP-P00084/2017-2018/10180) has been appointed as Interim Resolution Professional, with creditors required to submit claims by 27 May 2026. The process is estimated to close by 27 October 2026 (180 days from commencement), with no positive operational or financial metrics reported.

  • · Date of incorporation: 24 July 1990
  • · CIN: L45201DL1990PLC040945
  • · Registered office: Parsvnath Tower, Near Shahdara Metro Station, Shahdara, East Delhi, Delhi-110032
  • · Classes of creditors: Allottees under All Real Estate Projects of Parsvnath Developers Limited
  • · IRP correspondence address: 2, Community Centre, 3rd Floor, (Near PVR/McDonald), Naraina, New Delhi-110028; Email: parsvnathcirp@gmail.com
  • · Company Petition No.: (IB) NO. 468/PB/2024
  • · Scrip Codes: PARSVNATH-EQ (NSE); 532780 (BSE)
Kobo Biotech Ltd-$ Insolvency mixed materiality 10/10

13-05-2026

The National Company Law Tribunal (NCLT), Hyderabad Bench, approved the resolution plan for Kobo Biotech Limited submitted by Beaufond Industries Limited on May 11, 2026, involving a merger, demerger, and total payments of ₹70.11 Cr to creditors (₹67.78 Cr to financial creditors, ₹2.30 Cr to CIRP costs), averting liquidation. Pre-CIRP net worth stood at ₹132.91 Cr and assets at ₹71.39 Cr as of March 31, 2024, while the resolution applicant's net worth was ₹333.18 Cr as of March 31, 2025. However, existing promoters receive no shares, and public shareholders' stake is diluted from 55.05% to 2.00% post-scheme.

  • · All existing liabilities, claims, and dues against Kobo Biotech will be extinguished post-implementation with no residual liabilities surviving.
  • · No shares issued to pre-scheme promoters/promoter group of Kobo Biotech.
  • · Monitoring Committee to manage day-to-day affairs until handover; new board composition to be as per plan (details incomplete in filing).
  • · Resolution applicant net worth ₹333.18 Cr to merge with corporate debtor.
Tasty Dairy Specialities Limited Insolvency negative materiality 10/10

13-05-2026

Tasty Dairy Specialities Limited, under ongoing Corporate Insolvency Resolution Process (CIRP) since October 7, 2025 managed by Resolution Professional Anish Agarwal, submitted audited standalone financial results for the quarter and year ended March 31, 2026, approved by the RP on May 12, 2026. The auditor issued a Qualified Opinion, highlighting unresolved litigations, unrecognized SARFAESI asset sales still reflected in PPE, lack of impairment testing, incomplete Ind AS compliance, and uncertain trade receivables/payables with no adjustments made pending CIRP completion. These issues may have material and pervasive impacts on the financial statements, which report a net loss but with unascertainable consequential effects.

  • · CIRP order dated October 07, 2025; moratorium under Section 14 of IBC, 2016 in effect.
  • · Financial results considered and approved by RP between 14:00 and 14:30 Hours on May 12, 2026.
  • · Auditor: Neha B Agarwal & Co; report notes powers of Board suspended, assets managed by RP.
  • · Litigations include labour matters, arbitration, Debt Recovery Tribunal, SARFAESI proceedings; records incomplete.
  • · PPE carried at suspended management's values; no accounting for bank sales under SARFAESI.
  • · No impairment testing done pending CIRP; physical verification and valuations obtained but no impact recorded.

Get daily alerts with 10 investment signals, 7 risk alerts, 7 opportunities and full AI analysis of all 6 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India MCA Insolvency Liquidation Filings

🇮🇳 More from India

View all →